Skip to main content
HRES 26 107th Congress House Health Canada Commerce Drug industry Drugs Latin America Mexico Prescription pricing Price policy

Expressing the sense of the House of Representatives regarding the disparity between identical prescription drugs sold in the United States, Canada, and Mexico.

Introduced: January 31, 2001 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 14, 2001
Referred to the Subcommittee on Health.
Feb 1, 2001
Sponsor introductory remarks on measure. (CR E98)
Jan 31, 2001
Introduced in House
Jan 31, 2001
Referred to the House Committee on Energy and Commerce.
 Plain-English summary Congressional Research Service
Expresses the sense of the House of Representatives that the cost disparity between identical prescription drugs sold in the United States, Canada, and Mexico should be reduced or eliminated.
What's happening now February 14, 2001

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1